We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

96 hedge funds and large institutions have $571M invested in GenMark Diagnostics, Inc in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 18

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 99 → 96 (-3)

13% less capital invested

Capital invested by funds: $657M → $571M (-$85.9M)

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
96
Holders Change
-3
Holders Change %
-3.03%
% of All Funds
2.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
45
Reduced
18
Closed
16
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$59K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17M
2
CC
Casdin Capital
New York
+$8.47M
3
PI
Putnam Investments
Massachusetts
+$6.27M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.63M
5
PCM
Penn Capital Management
Pennsylvania
+$3.61M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$8.82M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.64M
3
Wells Fargo
Wells Fargo
California
-$2.65M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.38M
5
CRC
Curi RMB Capital
Illinois
-$2.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$79M +$1.87M +179,610 +2%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$63.5M +$17M +1,638,377 +33%
PI
3
Putnam Investments
Massachusetts
$46.7M +$6.27M +603,525 +14%
JP Morgan Chase
4
JP Morgan Chase
New York
$41.3M +$3.11M +299,173 +7%
CCM
5
Cadian Capital Management
New York
$38.8M +$490K +47,123 +1%
Jennison Associates
6
Jennison Associates
New York
$34.4M +$262K +25,254 +0.7%
BlackRock
7
BlackRock
New York
$32.7M +$3.48M +334,734 +11%
Vanguard Group
8
Vanguard Group
Pennsylvania
$22.7M +$2M +192,625 +9%
HighTower Advisors
9
HighTower Advisors
Illinois
$22.7M – – –
Artisan Partners
10
Artisan Partners
Wisconsin
$21.4M -$285K -27,471 -1%
NC
11
Northpointe Capital
Michigan
$15M +$3.16M +304,232 +24%
CC
12
Casdin Capital
New York
$14.4M +$8.47M +815,000 +119%
Millennium Management
13
Millennium Management
New York
$14.2M +$3.02M +290,343 +25%
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$10.1M -$3.64M -350,000 -25%
Alyeska Investment Group
15
Alyeska Investment Group
Illinois
$9.76M +$3.63M +349,819 +53%
State Street
16
State Street
Massachusetts
$9.31M +$815K +78,442 +9%
GTC
17
Ghost Tree Capital
New York
$9.15M +$1.3M +125,000 +15%
Morgan Stanley
18
Morgan Stanley
New York
$8.55M -$865K -83,265 -9%
Northern Trust
19
Northern Trust
Illinois
$6.73M +$711K +68,441 +11%
Thrivent Financial for Lutherans
20
Thrivent Financial for Lutherans
Minnesota
$5.67M +$645K +62,110 +12%
BG
21
Bellevue Group
Switzerland
$5.04M +$1.23M +118,499 +29%
New York State Common Retirement Fund
22
New York State Common Retirement Fund
New York
$4.56M – – –
MWNA
23
Marshall Wace North America
New York
$4.48M -$1M -96,366 -18%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$4.44M +$114K +11,019 +2%
Fidelity International
25
Fidelity International
Bermuda
$4.22M – – –
1
2 3 4 5

GNMK Hedge Fund Activity: Q3 2017 in Review

96 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2017, worth a combined $571M — down 13% from $657M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GNMK and 13 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 45 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $17M. The largest seller was Citadel Advisors, cutting an estimated $8.82M.

  • 96 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2017, down from 99 in Q2 2017.
  • Funds reported $571M of GenMark Diagnostics, Inc stock for Q3 2017, down 13% quarter-over-quarter.
  • 13 funds opened new GenMark Diagnostics, Inc positions in Q3 2017 and 16 closed out, a net change of -3 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2017 was T. Rowe Price Associates, an estimated $17M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2017 was Citadel Advisors, an estimated $8.82M sold.

Based on aggregated 13F filings for Q3 2017.